Boston scientific received information that this cardiac resynchronization therapy pacemaker (crt-p) was part of a system revision due to pocket infection and erosion.Reportedly, the patient's device site turned red soon after implant.The patient also had fever and pneumonia.The physician had cleaned up the pus and bleeding.A small hole was noted above the device site.Additional information received from the field representative indicates that the crt-p was explanted and then was used as an external temporary pacemaker.Moreover, the device was explanted.There were no additional adverse patient effects reported.The crt-p is no longer in service.
|